These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 18676566

  • 21. Measurement of growth in stimulant-naive children with attention-deficit/hyperactivity disorder by using cross-sectional and longitudinal approaches.
    Poulton A, Nanan R.
    Pediatrics; 2008 Jul; 122(1):221; author reply 221-2. PubMed ID: 18596017
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of attention deficit hyperactivity disorder.
    Frazier JP, Barratt MS, Smith KC.
    J Pediatr Health Care; 1999 Jul; 13(5):250-3. PubMed ID: 10776202
    [No Abstract] [Full Text] [Related]

  • 23. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 24. Electrocardiograms for attention deficit disorder.
    Moodie DS.
    Congenit Heart Dis; 2008 Jun; 3(5):307. PubMed ID: 18837807
    [No Abstract] [Full Text] [Related]

  • 25. Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.
    Warren AE, Hamilton RM, Bélanger SA, Gray C, Gow RM, Sanatani S, Côté JM, Lougheed J, LeBlanc J, Martin S, Miles B, Mitchell C, Gorman DA, Weiss M, Schachar R.
    Can J Cardiol; 2009 Nov; 25(11):625-30. PubMed ID: 19898693
    [Abstract] [Full Text] [Related]

  • 26. Stimulant medications and attention deficit-hyperactivity disorder.
    Cohen AL, Jhung MA, Budnitz DS.
    N Engl J Med; 2006 May 25; 354(21):2294-5. PubMed ID: 16723627
    [No Abstract] [Full Text] [Related]

  • 27. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ, Mikami AY, Cox BS, Coleman MT, Mahmood A, Sood A, Moore M, Burket R, Merkel RL.
    Arch Pediatr Adolesc Med; 2008 Aug 25; 162(8):793-4. PubMed ID: 18678816
    [No Abstract] [Full Text] [Related]

  • 28. Adolescent with history of hypercholesterolemia and ADHD: evidence-based practice.
    Muccino K.
    J Pediatr Health Care; 2009 Aug 25; 23(4):263-8. PubMed ID: 19559994
    [No Abstract] [Full Text] [Related]

  • 29. [Treatment with central nervous system stimulants].
    Zlotnik G.
    Ugeskr Laeger; 2004 Mar 01; 166(10):925; author reply 925. PubMed ID: 15045741
    [No Abstract] [Full Text] [Related]

  • 30. Attention deficit hyperactivity disorder.
    Morrell P.
    Indian Pediatr; 1998 Oct 01; 35(10):953-8. PubMed ID: 10216717
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Stimulants, ADHD, and the heart.
    Ganiats TG.
    Am Fam Physician; 2009 May 15; 79(10):846, 851. PubMed ID: 19496384
    [No Abstract] [Full Text] [Related]

  • 33. [Safety of drugs to treat attention deficit disorder with hyperactivity].
    Péluchon R.
    Soins Pediatr Pueric; 2012 May 15; (268):9. PubMed ID: 23074795
    [No Abstract] [Full Text] [Related]

  • 34. ADHD drugs and cardiovascular risk.
    Nissen SE.
    N Engl J Med; 2006 Apr 06; 354(14):1445-8. PubMed ID: 16549404
    [No Abstract] [Full Text] [Related]

  • 35. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.
    Hammerness P, Wilens T, Mick E, Spencer T, Doyle R, McCreary M, Becker J, Biederman J.
    J Pediatr; 2009 Jul 06; 155(1):84-9, 89.e1. PubMed ID: 19394037
    [Abstract] [Full Text] [Related]

  • 36. [Attention deficit hyperkinetic syndrome (ADHS) and stimulants].
    Rothenberger A.
    Z Kinder Jugendpsychiatr Psychother; 2002 Aug 06; 30(3):159-61. PubMed ID: 12227218
    [No Abstract] [Full Text] [Related]

  • 37. Cardiovascular effects of methylphenidate.
    Daniels SR.
    J Pediatr; 2009 Jul 06; 155(1):A3. PubMed ID: 19559283
    [No Abstract] [Full Text] [Related]

  • 38. Drugs and A.D.H.D.
    Blansfield HN.
    Conn Med; 2000 Jun 06; 64(6):355-6. PubMed ID: 10909199
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. ADHD drugs and cardiovascular risk.
    Anders T, Sharfstein S.
    N Engl J Med; 2006 May 25; 354(21):2296-8; author reply 2296-8. PubMed ID: 16723628
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.